Symbols / RCEL $4.47 -3.25%
RCEL Chart
About
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting device with ease-of-use, an enhanced ease-of-use device that can treat areas of up to 1,920 cm²; and RECELL GO mini autologous cell harvesting device, a line extension of the RECELL GO system to treat smaller wounds up to 480 cm2, as well as RECELL GO autologous cell harvesting device consisting of RECELL GO processing device, which controls and manages the pressure applied to disaggregate the donor skin cells and controls the incubation time of the RECELL Enzyme to optimize cell yield and promote cell viability; and RECELL GO preparation kit, which can treat areas up to 1,920 cm2. In addition, the company sells and distributes PermeaDerm, a biosynthetic wound matrix and Cohealyx, a collagen-based dermal matrix. It serves hospitals, treatment centers, and distributors. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical, Inc. in December 2020. AVITA Medical, Inc. is headquartered in Valencia, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 136.92M |
| Enterprise Value | 164.79M | Income | -48.59M | Sales | 71.61M |
| Book/sh | -0.55 | Cash/sh | 0.59 | Dividend Yield | — |
| Payout | 0.00% | Employees | 226 | IPO | — |
| P/E | — | Forward P/E | -21.92 | PEG | — |
| P/S | 1.91 | P/B | -8.20 | P/C | — |
| EV/EBITDA | -4.09 | EV/Sales | 2.30 | Quick Ratio | 0.43 |
| Current Ratio | 0.57 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -1.74 | EPS next Y | -0.20 | EPS Growth | — |
| Revenue Growth | -4.30% | Earnings | 2026-05-07 | ROA | -39.06% |
| ROE | — | ROIC | — | Gross Margin | 82.13% |
| Oper. Margin | -59.09% | Profit Margin | -67.85% | Shs Outstand | 30.63M |
| Shs Float | 30.28M | Short Float | 12.54% | Short Ratio | 15.73 |
| Short Interest | — | 52W High | 10.29 | 52W Low | 3.22 |
| Beta | 1.81 | Avg Volume | 225.13K | Volume | 113.31K |
| Target Price | $8.54 | Recom | Strong_buy | Prev Close | $4.62 |
| Price | $4.47 | Change | -3.25% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$8.54
Mean price target
2. Current target
$4.47
Latest analyst target
3. DCF / Fair value
$-10.77
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.47
Low
$5.51
High
$10.07
Mean
$8.54
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-03-05 | init | Northland Capital Markets | — → Outperform | $10 |
| 2026-02-17 | main | D. Boral Capital | Buy → Buy | $10 |
| 2026-01-26 | main | D. Boral Capital | Buy → Buy | $10 |
| 2026-01-16 | main | Lake Street | Hold → Hold | $4 |
| 2026-01-15 | main | D. Boral Capital | Buy → Buy | $10 |
| 2025-11-20 | up | BTIG | Sell → Neutral | — |
| 2025-11-07 | main | D. Boral Capital | Buy → Buy | $14 |
| 2025-10-17 | down | Lake Street | Buy → Hold | $4 |
| 2025-10-17 | main | D. Boral Capital | Buy → Buy | $14 |
| 2025-09-15 | main | D. Boral Capital | Buy → Buy | $14 |
| 2025-09-05 | main | D. Boral Capital | Buy → Buy | $14 |
| 2025-08-11 | main | Lake Street | Buy → Buy | $8 |
| 2025-08-08 | main | D. Boral Capital | Buy → Buy | $18 |
| 2025-06-10 | main | D. Boral Capital | Buy → Buy | $19 |
| 2025-06-06 | main | D. Boral Capital | Buy → Buy | $19 |
| 2025-04-10 | main | D. Boral Capital | Buy → Buy | $22 |
| 2025-04-04 | main | D. Boral Capital | Buy → Buy | $22 |
| 2025-03-18 | main | D. Boral Capital | Buy → Buy | $22 |
| 2025-02-20 | main | D. Boral Capital | Buy → Buy | $22 |
| 2025-02-14 | main | D. Boral Capital | Buy → Buy | $25 |
- Wall Street Analysts Believe Avita Medical (RCEL) Could Rally 29.87%: Here's is How to Trade - Yahoo Finance Wed, 25 Feb 2026 08
- $RCEL stock is up 32% today. Here's what we see in our data. - Quiver Quantitative Mon, 15 Sep 2025 07
- AVITA Medical outlines $80–85M 2026 sales and new $60M credit deal - Stock Titan ue, 13 Jan 2026 08
- There's No Escaping AVITA Medical, Inc.'s (NASDAQ:RCEL) Muted Revenues Despite A 26% Share Price Rise - simplywall.st Sat, 24 Jan 2026 08
- Avita Medical Stock: Skin Regeneration Platform Is Set Up For A Turnaround (NASDAQ:RCEL) - Seeking Alpha Wed, 28 Jan 2026 08
- Avita Medical (RCEL) Stock Surges 35% Following CE Certification - GuruFocus Mon, 15 Sep 2025 07
- AVITA Medical (RCEL): Evaluating Valuation After CEO Change, Board Reshuffle, and Updated Financial Guidance - Yahoo Finance Sun, 19 Oct 2025 07
- RCEL SEC Filings - Avita Medical Inc 10-K, 10-Q, 8-K Forms - Stock Titan Sat, 28 Feb 2026 04
- AVITA Medical, Inc.'s (NASDAQ:RCEL) Path To Profitability - simplywall.st Sat, 17 Jan 2026 08
- Avita Medical: Green Shoots Peaking Out From Hard Clay (NASDAQ:RCEL) - Seeking Alpha ue, 26 Aug 2025 07
- Medicare hurdles ease as burn-care firm AVITA Medical secures $60M credit line - Stock Titan hu, 12 Feb 2026 08
- Avita Medical (RCEL) Upgraded to Buy: Here's What You Should Know - Yahoo Finance hu, 19 Feb 2026 08
- AVITA Medical (RCEL) Is Down 22.4% After CEO Departure and Revenue Guidance Cut—Has the Thesis Changed? - simplywall.st Sat, 18 Oct 2025 07
- AVITA Medical Raises US$15M from Australian Investors to Fuel Growth Until Cash Flow Positive - Stock Titan ue, 12 Aug 2025 07
- What To Expect From AVITA Medical Inc (RCEL) Q3 2025 Earnings - Yahoo Finance Wed, 05 Nov 2025 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.21 | 0.21 | 0.21 | 0.21 |
| NormalizedEBITDA | -41.23M | -55.30M | -33.54M | -26.05M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -48.59M | -61.84M | -35.38M | -26.66M |
| ReconciledDepreciation | 2.35M | 1.13M | 632.00K | 568.00K |
| ReconciledCostOfRevenue | 12.79M | 9.09M | 7.78M | 6.04M |
| EBITDA | -41.23M | -55.30M | -33.54M | -26.05M |
| EBIT | -43.57M | -56.43M | -34.17M | -26.61M |
| NetInterestIncome | -5.00M | -5.36M | -1.14M | -16.00K |
| InterestExpense | 5.00M | 5.36M | 1.14M | 16.00K |
| NormalizedIncome | -48.59M | -61.84M | -35.38M | -26.66M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -48.59M | -61.84M | -35.38M | -26.66M |
| TotalExpenses | 114.14M | 120.84M | 92.80M | 61.93M |
| TotalOperatingIncomeAsReported | -42.53M | -56.59M | -42.66M | -27.50M |
| DilutedAverageShares | 27.86M | 25.88M | 25.33M | 25.00M |
| BasicAverageShares | 27.86M | 25.88M | 25.33M | 25.00M |
| DilutedEPS | -1.74 | -2.39 | -1.40 | -1.07 |
| BasicEPS | -1.74 | -2.39 | -1.40 | -1.07 |
| DilutedNIAvailtoComStockholders | -48.59M | -61.84M | -35.38M | -26.66M |
| NetIncomeCommonStockholders | -48.59M | -61.84M | -35.38M | -26.66M |
| NetIncome | -48.59M | -61.84M | -35.38M | -26.66M |
| NetIncomeIncludingNoncontrollingInterests | -48.59M | -61.84M | -35.38M | -26.66M |
| NetIncomeContinuousOperations | -48.59M | -61.84M | -35.38M | -26.66M |
| TaxProvision | 11.00K | 54.00K | 66.00K | 36.00K |
| PretaxIncome | -48.58M | -61.79M | -35.31M | -26.63M |
| OtherIncomeExpense | -1.04M | 163.00K | 8.48M | 892.00K |
| OtherNonOperatingIncomeExpenses | -1.04M | 163.00K | 8.48M | 892.00K |
| NetNonOperatingInterestIncomeExpense | -5.00M | -5.36M | -1.14M | -16.00K |
| InterestExpenseNonOperating | 5.00M | 5.36M | 1.14M | 16.00K |
| OperatingIncome | -42.53M | -56.59M | -42.66M | -27.50M |
| OperatingExpense | 101.35M | 111.75M | 85.02M | 55.88M |
| OtherOperatingExpenses | -1.43M | -3.21M | -2.06M | |
| ResearchAndDevelopment | 20.84M | 20.36M | 20.82M | 13.86M |
| SellingGeneralAndAdministration | 80.51M | 91.39M | 65.62M | 45.24M |
| SellingAndMarketingExpense | 53.14M | 58.20M | 37.29M | 21.91M |
| GeneralAndAdministrativeExpense | 27.37M | 33.20M | 28.33M | 23.33M |
| OtherGandA | 27.37M | 33.20M | 28.33M | 23.33M |
| GrossProfit | 58.82M | 55.16M | 42.36M | 28.38M |
| CostOfRevenue | 12.79M | 9.09M | 7.78M | 6.04M |
| TotalRevenue | 71.61M | 64.25M | 50.14M | 34.42M |
| OperatingRevenue | 71.61M | 64.25M | 50.14M | 34.42M |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 30.57M | 26.35M | 25.68M | 25.21M |
| ShareIssued | 30.57M | 26.35M | 25.68M | 25.21M |
| NetDebt | 32.74M | 28.20M | 17.69M | |
| TotalDebt | 46.05M | 45.98M | 42.41M | 918.00K |
| TangibleBookValue | -22.30M | -1.07M | 48.57M | 84.28M |
| InvestedCapital | 26.33M | 46.74M | 88.87M | 84.74M |
| WorkingCapital | -27.19M | 36.84M | 90.81M | 76.77M |
| NetTangibleAssets | -22.30M | -1.07M | 48.57M | 84.28M |
| CapitalLeaseObligations | 3.06M | 3.74M | 2.60M | 918.00K |
| CommonStockEquity | -16.65M | 4.50M | 49.06M | 84.74M |
| TotalCapitalization | -16.65M | 46.74M | 88.87M | 84.74M |
| TotalEquityGrossMinorityInterest | -16.65M | 4.50M | 49.06M | 84.74M |
| StockholdersEquity | -16.65M | 4.50M | 49.06M | 84.74M |
| OtherEquityInterest | -1.29M | -1.32M | -1.13M | -127.00K |
| GainsLossesNotAffectingRetainedEarnings | -1.37M | -1.94M | -1.89M | 7.63M |
| OtherEquityAdjustments | -1.37M | -1.94M | -1.89M | 7.63M |
| RetainedEarnings | -408.40M | -359.81M | -297.97M | -262.59M |
| AdditionalPaidInCapital | 394.41M | 367.57M | 350.04M | 339.82M |
| CapitalStock | 3.00K | 3.00K | 3.00K | 3.00K |
| CommonStock | 3.00K | 3.00K | 3.00K | 3.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 73.04M | 75.21M | 62.58M | 13.52M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 10.37M | 55.05M | 49.38M | 2.83M |
| OtherNonCurrentLiabilities | 3.00M | 3.00M | 503.00K | |
| PreferredSecuritiesOutsideStockEquity | 0.00 | 244.00K | 693.00K | 557.00K |
| DerivativeProductLiabilities | 1.24M | 3.43M | 3.16M | 0.00 |
| NonCurrentDeferredLiabilities | 3.99M | 3.29M | 4.02M | 1.97M |
| NonCurrentDeferredRevenue | 290.00K | 324.00K | 357.00K | 698.00K |
| LongTermDebtAndCapitalLeaseObligation | 2.13M | 45.09M | 41.51M | 306.00K |
| LongTermCapitalLeaseObligation | 2.13M | 2.84M | 1.70M | 306.00K |
| LongTermDebt | 42.24M | 39.81M | ||
| CurrentLiabilities | 62.68M | 20.16M | 13.20M | 10.69M |
| OtherCurrentLiabilities | 1.72M | 419.00K | 371.00K | 184.00K |
| CurrentDeferredLiabilities | 276.00K | 2.09M | 168.00K | 272.00K |
| CurrentDeferredRevenue | 33.00K | 0.00 | ||
| CurrentDebtAndCapitalLeaseObligation | 43.91M | 900.00K | 895.00K | 612.00K |
| CurrentCapitalLeaseObligation | 929.00K | 900.00K | 895.00K | 612.00K |
| CurrentDebt | 42.98M | |||
| OtherCurrentBorrowings | 42.98M | |||
| PayablesAndAccruedExpenses | 16.77M | 16.75M | 11.77M | 9.62M |
| CurrentAccruedExpenses | 7.81M | 10.45M | 7.97M | 6.62M |
| Payables | 8.96M | 6.29M | 3.79M | 3.00M |
| AccountsPayable | 8.96M | 6.29M | 3.79M | 3.00M |
| TotalAssets | 56.39M | 79.71M | 111.64M | 98.26M |
| TotalNonCurrentAssets | 20.90M | 22.71M | 7.63M | 10.81M |
| OtherNonCurrentAssets | 3.73M | 3.55M | 2.83M | 1.24M |
| DefinedPensionBenefit | 1.24M | |||
| NonCurrentPrepaidAssets | 303.00K | 122.00K | 148.00K | |
| NonCurrentDeferredAssets | 0.00 | 613.00K | ||
| InvestmentsAndAdvances | 0.00 | 6.93M | 0.00 | |
| OtherInvestments | 0.00 | |||
| InvestmentinFinancialAssets | 0.00 | 6.93M | 0.00 | |
| AvailableForSaleSecurities | 6.93M | |||
| GoodwillAndOtherIntangibleAssets | 5.64M | 5.57M | 487.00K | 465.00K |
| OtherIntangibleAssets | 5.64M | 5.57M | 487.00K | 465.00K |
| NetPPE | 11.53M | 13.59M | 4.32M | 2.05M |
| AccumulatedDepreciation | -5.11M | -3.45M | -2.43M | -2.15M |
| GrossPPE | 16.63M | 17.04M | 6.75M | 4.20M |
| Leases | 4.88M | 4.61M | 367.00K | 257.00K |
| ConstructionInProgress | 17.00K | 442.00K | 87.00K | 258.00K |
| OtherProperties | 7.72M | 8.33M | 3.65M | 1.62M |
| MachineryFurnitureEquipment | 4.01M | 3.66M | 2.65M | 2.06M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 35.49M | 57.00M | 104.01M | 87.46M |
| OtherCurrentAssets | 1.27M | 1.88M | 1.43M | |
| RestrictedCash | 0.00 | 201.00K | ||
| PrepaidAssets | 1.41M | 1.03M | 853.00K | |
| Inventory | 6.93M | 7.27M | 5.60M | 2.12M |
| FinishedGoods | 4.92M | 4.43M | 1.03M | 610.00K |
| WorkInProcess | 116.00K | 389.00K | 878.00K | 384.00K |
| RawMaterials | 1.90M | 2.45M | 3.68M | 1.13M |
| Receivables | 9.11M | 11.96M | 7.92M | 4.96M |
| OtherReceivables | 21.00K | 177.00K | 257.00K | 1.45M |
| AccountsReceivable | 9.09M | 11.79M | 7.66M | 3.52M |
| AllowanceForDoubtfulAccountsReceivable | -61.00M | -71.00M | -48.00M | -24.00M |
| GrossAccountsReceivable | 70.09M | 82.79M | 55.66M | 27.52M |
| CashCashEquivalentsAndShortTermInvestments | 18.18M | 35.88M | 89.06M | 79.34M |
| OtherShortTermInvestments | 7.94M | 21.84M | 66.94M | 61.18M |
| CashAndCashEquivalents | 10.24M | 14.05M | 22.12M | 18.16M |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -32.93M | -58.27M | -39.46M | -19.61M |
| RepaymentOfDebt | 0.00 | -11.00K | ||
| IssuanceOfDebt | 0.00 | 38.76M | 0.00 | |
| IssuanceOfCapitalStock | 14.79M | 0.00 | 0.00 | 69.11M |
| CapitalExpenditure | -1.74M | -9.33M | -1.45M | -525.00K |
| InterestPaidSupplementalData | 5.36M | 1.14M | 15.00K | 3.00K |
| IncomeTaxPaidSupplementalData | 41.00K | 44.00K | 17.00K | 42.00K |
| EndCashPosition | 10.24M | 14.05M | 22.12M | 18.16M |
| BeginningCashPosition | 14.05M | 22.12M | 18.16M | 55.71M |
| EffectOfExchangeRateChanges | 0.00 | -16.00K | -26.00K | 133.00K |
| ChangesInCash | -3.81M | -8.07M | 3.97M | -37.52M |
| FinancingCashFlow | 14.94M | 3.51M | 40.37M | 900.00K |
| CashFlowFromContinuingFinancingActivities | 14.94M | 3.51M | 40.37M | 900.00K |
| NetOtherFinancingCharges | -1.06M | -5.11M | ||
| ProceedsFromStockOptionExercised | 1.20M | 3.51M | 1.61M | 900.00K |
| NetCommonStockIssuance | 14.79M | 0.00 | 0.00 | 69.11M |
| CommonStockIssuance | 14.79M | 0.00 | 0.00 | 69.11M |
| NetIssuancePaymentsOfDebt | 0.00 | 38.76M | 0.00 | -11.00K |
| NetLongTermDebtIssuance | 0.00 | 38.76M | 0.00 | -11.00K |
| LongTermDebtPayments | 0.00 | -11.00K | ||
| LongTermDebtIssuance | 0.00 | 38.76M | 0.00 | |
| InvestingCashFlow | 12.45M | 37.36M | 1.61M | -19.33M |
| CashFlowFromContinuingInvestingActivities | 12.45M | 37.36M | 1.61M | -19.33M |
| NetInvestmentPurchaseAndSale | 14.19M | 46.70M | 3.05M | -18.81M |
| SaleOfInvestment | 27.50M | 71.20M | 81.81M | 55.55M |
| PurchaseOfInvestment | -13.31M | -24.50M | -78.76M | -74.36M |
| NetIntangiblesPurchaseAndSale | -99.00K | -162.00K | -66.00K | -73.00K |
| PurchaseOfIntangibles | -99.00K | -162.00K | -66.00K | -73.00K |
| NetPPEPurchaseAndSale | -1.00M | -9.17M | -1.38M | -452.00K |
| PurchaseOfPPE | -1.00M | -9.17M | -1.38M | -452.00K |
| CapitalExpenditureReported | -635.00K | 0.00 | ||
| OperatingCashFlow | -31.20M | -48.94M | -38.01M | -19.09M |
| CashFlowFromContinuingOperatingActivities | -31.20M | -48.94M | -38.01M | -19.09M |
| ChangeInWorkingCapital | 3.44M | -4.68M | -6.57M | -1.20M |
| ChangeInOtherWorkingCapital | 46.00K | 425.00K | 406.00K | 740.00K |
| ChangeInOtherCurrentLiabilities | -986.00K | -784.00K | -447.00K | -862.00K |
| ChangeInOtherCurrentAssets | 341.00K | -462.00K | -1.24M | -906.00K |
| ChangeInPayablesAndAccruedExpense | 107.00K | 2.82M | 2.16M | 1.55M |
| ChangeInAccruedExpense | -2.64M | 2.48M | 1.35M | 1.27M |
| ChangeInPayable | 2.75M | 340.00K | 809.00K | 282.00K |
| ChangeInAccountPayable | 2.75M | 340.00K | 809.00K | 282.00K |
| ChangeInPrepaidAssets | 766.00K | -371.00K | -451.00K | -366.00K |
| ChangeInInventory | -468.00K | -2.16M | -3.69M | -371.00K |
| ChangeInReceivables | 3.63M | -4.14M | -3.30M | -985.00K |
| ChangesInAccountReceivables | 3.63M | -4.14M | -4.17M | -395.00K |
| OtherNonCashItems | 3.16M | 3.71M | 4.61M | 1.20M |
| StockBasedCompensation | 9.52M | 13.50M | 8.38M | 7.00M |
| ProvisionandWriteOffofAssets | -10.00K | 23.00K | 24.00K | -5.00K |
| AssetImpairmentCharge | 821.00K | 503.00K | 225.00K | 375.00K |
| AmortizationOfSecurities | -308.00K | -1.67M | -1.38M | -281.00K |
| DeferredTax | 0.00 | |||
| DeferredIncomeTax | 0.00 | |||
| DepreciationAmortizationDepletion | 2.35M | 1.13M | 632.00K | 568.00K |
| DepreciationAndAmortization | 2.35M | 1.13M | 632.00K | 568.00K |
| OperatingGainsLosses | -1.58M | 402.00K | -8.54M | -82.00K |
| PensionAndEmployeeBenefitExpense | 856.00K | 38.00K | ||
| GainLossOnInvestmentSecurities | -2.19M | 274.00K | 750.00K | |
| NetForeignCurrencyExchangeGainLoss | 17.00K | 21.00K | -9.38M | -85.00K |
| GainLossOnSaleOfPPE | 595.00K | 107.00K | 83.00K | 3.00K |
| NetIncomeFromContinuingOperations | -48.59M | -61.84M | -35.38M | -26.66M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for RCEL
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|